HK1083769A1 - Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same - Google Patents
Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the sameInfo
- Publication number
- HK1083769A1 HK1083769A1 HK06106212.3A HK06106212A HK1083769A1 HK 1083769 A1 HK1083769 A1 HK 1083769A1 HK 06106212 A HK06106212 A HK 06106212A HK 1083769 A1 HK1083769 A1 HK 1083769A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- producing
- same
- digestive tract
- agent improving
- mediated absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003006005 | 2003-01-14 | ||
PCT/JP2004/000070 WO2004062691A1 (ja) | 2003-01-14 | 2004-01-08 | プロトン駆動型トランスポーター介在型消化管吸収改善剤及びその製法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1083769A1 true HK1083769A1 (en) | 2006-07-14 |
Family
ID=32709038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106212.3A HK1083769A1 (en) | 2003-01-14 | 2006-05-29 | Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
Country Status (11)
Country | Link |
---|---|
US (3) | US20060121107A1 (xx) |
EP (1) | EP1588715A4 (xx) |
JP (2) | JP5175032B2 (xx) |
KR (1) | KR100691568B1 (xx) |
CN (1) | CN1735435B (xx) |
AR (1) | AR042846A1 (xx) |
AU (1) | AU2004204541B2 (xx) |
CA (1) | CA2508932C (xx) |
HK (1) | HK1083769A1 (xx) |
TW (1) | TWI355276B (xx) |
WO (1) | WO2004062691A1 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102908332B (zh) * | 2011-08-04 | 2014-04-16 | 纳米及先进材料研发院有限公司 | 用于口服胰岛素递送的包含阳离子纳米粒子的肠溶包衣胶囊 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3148124A (en) * | 1962-06-12 | 1964-09-08 | William E Gaunt | Method of preparing sustained release pharmaceutical tablets |
US4224929A (en) * | 1977-11-08 | 1980-09-30 | Olympus Optical Co., Ltd. | Endoscope with expansible cuff member and operation section |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5322697A (en) * | 1992-05-28 | 1994-06-21 | Meyer James H | Composition and method for inducing satiety |
KR0157280B1 (ko) * | 1992-11-06 | 1998-11-16 | 나까토미 히로타카 | 하부소화관 방출성의 경구의약제제 |
US5358502A (en) * | 1993-02-25 | 1994-10-25 | Pfizer Inc | PH-triggered osmotic bursting delivery devices |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
GB9412394D0 (en) * | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
US5728402A (en) * | 1994-11-16 | 1998-03-17 | Andrx Pharmaceuticals Inc. | Controlled release formulation of captopril or a prodrug of captopril |
WO1996020001A1 (fr) * | 1994-12-28 | 1996-07-04 | Teikoku Hormone Mfg. Co., Ltd. | Preparation traversant la muqueuse |
JPH09188617A (ja) * | 1996-01-08 | 1997-07-22 | Pola Chem Ind Inc | 徐放性医薬組成物 |
DE19631084A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
US5851985A (en) * | 1996-08-16 | 1998-12-22 | Tepic; Slobodan | Treatment of tumors by arginine deprivation |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
EA003101B1 (ru) * | 1998-03-19 | 2002-12-26 | Бристол-Майерз Сквибб Компани | Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы |
JP2000086535A (ja) * | 1998-09-14 | 2000-03-28 | Eisai Co Ltd | 遅延型速放固形製剤及びその製法 |
KR100762475B1 (ko) * | 1998-11-27 | 2007-10-04 | 칸지 타카다 | 위장내 약물 전달을 위한 경구용 제제 |
PT1194124E (pt) | 1999-06-11 | 2004-02-27 | Ranbaxy Lab Ltd | Composicoes de sabor mascarado |
KR100572506B1 (ko) * | 1999-06-14 | 2006-04-24 | 데이진 가부시키가이샤 | 2축 배향 폴리에스테르 필름 및 자기 기록 매체 |
KR100863146B1 (ko) * | 2000-07-17 | 2008-10-14 | 아스텔라스세이야쿠 가부시키가이샤 | 경구 흡수 개선 의약 조성물 |
US7803392B2 (en) * | 2000-12-27 | 2010-09-28 | University Of Kentucky Research Foundation | pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules |
DE60206889T2 (de) * | 2001-02-27 | 2006-07-27 | Astrazeneca Ab | Pharmazeutische formulierung enthaltend bicalutamid |
JP3942846B2 (ja) * | 2001-06-21 | 2007-07-11 | 独立行政法人科学技術振興機構 | 組織特異的トランスポーター阻害剤 |
CN1211422C (zh) * | 2001-08-01 | 2005-07-20 | 华中科技大学 | 用于口服结肠定位释药的聚合物凝胶及其制备方法 |
-
2004
- 2004-01-05 TW TW093100126A patent/TWI355276B/zh not_active IP Right Cessation
- 2004-01-08 AU AU2004204541A patent/AU2004204541B2/en not_active Ceased
- 2004-01-08 CA CA2508932A patent/CA2508932C/en not_active Expired - Fee Related
- 2004-01-08 JP JP2005507975A patent/JP5175032B2/ja not_active Expired - Fee Related
- 2004-01-08 KR KR1020057012945A patent/KR100691568B1/ko not_active IP Right Cessation
- 2004-01-08 EP EP04700783A patent/EP1588715A4/en not_active Withdrawn
- 2004-01-08 US US10/541,019 patent/US20060121107A1/en not_active Abandoned
- 2004-01-08 CN CN2004800021318A patent/CN1735435B/zh not_active Expired - Fee Related
- 2004-01-08 WO PCT/JP2004/000070 patent/WO2004062691A1/ja active Application Filing
- 2004-01-13 AR ARP040100078A patent/AR042846A1/es not_active Application Discontinuation
-
2006
- 2006-05-29 HK HK06106212.3A patent/HK1083769A1/xx not_active IP Right Cessation
-
2008
- 2008-01-09 US US11/971,243 patent/US20080119568A1/en not_active Abandoned
- 2008-10-21 US US12/254,905 patent/US8871818B2/en not_active Expired - Fee Related
-
2010
- 2010-08-12 JP JP2010181074A patent/JP2010280705A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPWO2004062691A1 (ja) | 2006-05-18 |
KR100691568B1 (ko) | 2007-03-09 |
TWI355276B (en) | 2012-01-01 |
US20090048350A1 (en) | 2009-02-19 |
JP5175032B2 (ja) | 2013-04-03 |
US20080119568A1 (en) | 2008-05-22 |
CA2508932A1 (en) | 2004-07-29 |
US20060121107A1 (en) | 2006-06-08 |
CA2508932C (en) | 2012-01-03 |
TW200413007A (en) | 2004-08-01 |
US8871818B2 (en) | 2014-10-28 |
JP2010280705A (ja) | 2010-12-16 |
EP1588715A4 (en) | 2011-05-25 |
AU2004204541B2 (en) | 2008-10-16 |
WO2004062691A1 (ja) | 2004-07-29 |
KR20050100369A (ko) | 2005-10-18 |
AR042846A1 (es) | 2005-07-06 |
CN1735435B (zh) | 2012-08-29 |
EP1588715A1 (en) | 2005-10-26 |
AU2004204541A1 (en) | 2004-07-29 |
CN1735435A (zh) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0519316D0 (en) | "Method and apparatus" | |
EG24489A (en) | Reducing agent for the soluble chromate content ofcement and methods for the production thereof | |
IL175892A0 (en) | Quinolines useful in treating cardiovascular disease | |
EP1785410A4 (en) | MONOETHERS OF POLYGLYCEROL AND PROCESS FOR THEIR PREPARATION | |
EP1729881A4 (en) | AQUEOUS LIQUID ABSORBENT MEDIUM AND METHOD OF MANUFACTURING THEREOF | |
IL172316A0 (en) | Novel compounds and their use in therapy | |
AU2003248074A8 (en) | Composite nanoparticle and process for producing the same | |
EP1550688A4 (en) | ORGANOPOLYSILOXANE-MODIFIED POLYSACCHARIDE AND PROCESS FOR PRODUCING THE SAME | |
EP1731139A4 (en) | PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR | |
AU2003268003A8 (en) | Diamondoid-based components in nanoscale construction | |
GB2418856B (en) | Breath freshener and process for producing the same | |
HK1087893A1 (en) | Masticatable capsule and process for producing the same | |
EP1586445A4 (en) | MULTILAYER BODY AND METHOD FOR PRODUCING THE SAME | |
EP1698647A4 (en) | POLYMER AND PROCESS FOR PRODUCING THE SAME | |
EP1840948A4 (en) | FINE TREATMENT AGENT AND FINE TREATMENT METHOD USING THE SAME | |
EP1640153A4 (en) | MULTILAYER BODY AND METHOD FOR PRODUCING THE SAME | |
EP1604710A4 (en) | SURFACE MATERIAL FOR BALLOON AND BALLOON | |
EP1669408A4 (en) | BALL-MOLDED COMPOSITION COMPOSITION AND METHOD OF MANUFACTURING THEREOF | |
HK1083769A1 (en) | Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same | |
EP1667174A4 (en) | SUPERCONDUCTOR AND METHOD FOR PRODUCING THE SAME | |
EP1627645A4 (en) | ANTITUMMER AGENT AND METHOD FOR PRODUCING THE SAME | |
SI1639013T1 (sl) | Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji | |
GB0625794D0 (en) | Condom and process for producing the same | |
PT1763515E (pt) | Ácidos 4-trifluorometoxifenoxibenzeno-4¿-sulfónicos, processo para a sua preparação e utilização em medicamentos | |
EP1685822A4 (en) | GLUCOSE ABSORPTION INHIBITOR AND METHOD FOR PRODUCING THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180108 |